Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Onconetix, Inc.BWV · Entity 8471 | Director | May 04, 2022 | May 27, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Onconetix, Inc.
Report date May 04, 2022 · Filed May 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.45 · Expires 2032-05-04 | Direct | 4,655 |
Reported balance
After 2022-05-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-04 · Grant · Acquired 4,655 · Balance 4,655 F1: Stock options (the "Options") were granted to Mr. Venerable on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock options (the "Options") were granted to Mr. Venerable on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2022 Filed May 27, 2022 10:44 UTC | Onconetix, Inc. BWV · Entity 8471 | GrantStock Option · Derivative | 4,655 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001213900-22-030001 · ownership.xml · derivative · entry 1 Venerable Michael · CIK 0001895466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,655 Underlying: Common Stock, par value $0.00001 per share · 4,655 shares Expires 2032-05-04 F1 · derivative.exercise_date: Stock options (the "Options") were granted to Mr. Venerable on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.